Management of Oligohydramnios

Diagnostic Confirmation

The American College of Obstetricians and Gynecologists recommends using Maximum Vertical Pocket (MVP) < 2 cm rather than Amniotic Fluid Index (AFI) < 5 cm for diagnosis of oligohydramnios, as MVP reduces false-positive diagnoses by approximately 50% and prevents unnecessary interventions without missing true pathology 1, 2
A detailed fetal anatomical survey focusing on the genitourinary system is recommended, as these represent the most common structural causes of oligohydramnios 1
Assessing for uteroplacental insufficiency by measuring fetal growth parameters and umbilical artery Doppler velocimetry is crucial in the diagnosis of oligohydramnios 1
In twin pregnancies, oligohydramnios in one sac may indicate twin-twin transfusion syndrome (TTTS) in monochorionic twins or uteroplacental insufficiency in dichorionic twins, with a 10-30% risk of neurologic injury and 10% risk of co-twin demise 3, 4

The American College of Obstetricians and Gynecologists recommends weekly monitoring, including maternal vital signs, fetal heart rate assessment, and evaluation for signs of infection, for outpatient management of oligohydramnios before viability (< 24 weeks) 1, 2
Increasing surveillance frequency is recommended if maternal symptoms develop, such as shortness of breath, increasing abdominal girth, contractions, or pelvic pressure 4
After viability (≥ 24 weeks), performing biophysical profile (BPP) or modified BPP regularly, and including umbilical artery Doppler velocimetry in all surveillance, is recommended, particularly when fetal growth restriction is suspected or confirmed 1, 2
The American College of Obstetricians and Gynecologists recommends increasing surveillance to twice weekly or more when severe oligohydramnios (MVP < 1 cm) is present or when associated with growth restriction 1

Hospitalization is immediately recommended when severe oligohydramnios with non-reassuring fetal surveillance, evidence of hemorrhage, infection, or fetal demise is present 1, 2
Outpatient management is acceptable when previable gestation with stable maternal status and no contraindications is present, or when isolated oligohydramnios at term without other concerning findings is present, though close surveillance is required 1, 2

The American College of Obstetricians and Gynecologists recommends delivering between 34 0/7 to 37 6/7 weeks when oligohydramnios is associated with fetal growth restriction, with a strength of evidence level of moderate 1, 2
Delivering earlier than 34 weeks is recommended if abnormal umbilical artery Doppler or evidence of cardiovascular compromise develops, with a strength of evidence level of high 1
Administering antenatal corticosteroids is recommended if delivery is anticipated within 7 days, with a strength of evidence level of strong 1

The American College of Obstetricians and Gynecologists recommends not using AFI alone for diagnosis in early pregnancy, as it leads to overdiagnosis compared to MVP, resulting in unnecessary interventions without improving outcomes, with a strength of evidence level of moderate 1, 2
Delaying appropriate delivery after 34 weeks when oligohydramnios is associated with abnormal fetal surveillance is not recommended, as stillbirth risk is significantly increased, with a strength of evidence level of high 1, 2
Managing severe early-onset oligohydramnios without multidisciplinary involvement, including maternal-fetal medicine specialists and neonatology, is not recommended, with a strength of evidence level of strong 1
Relying solely on isolated oligohydramnios without other concerning findings to make delivery decisions is not recommended, as meta-analyses show no differences in Apgar scores, pH, or NICU admissions in isolated cases at term, with a strength of evidence level of moderate 2
Missing TTTS in monochorionic twins, where oligohydramnios in one sac with polyhydramnios in the other requires immediate specialized evaluation, is not recommended, with a strength of evidence level of high 3, 4